Table 2 KEGG enrichment analysis
From: Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
ID | Description | P adjust |
|---|---|---|
hsa04080 | Neuroactive ligand-receptor interaction | 1.65E−13 |
hsa05033 | Nicotine addiction | 0.000143 |
hsa00982 | Drug metabolism-cytochrome P450 | 0.000789 |
hsa04024 | cAMP signaling pathway | 0.001009 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 0.001102 |
hsa05322 | Systemic lupus erythematosus | 0.001329 |
hsa00830 | Retinol metabolism | 0.005698 |
hsa04742 | Taste transduction | 0.008404 |
hsa00590 | Arachidonic acid metabolism | 0.009237 |
hsa00591 | Linoleic acid metabolism | 0.013333 |